Regenerative Medicine Market In-Depth Research On Basis By Product (Cell-based Immunotherapies, Gene Therapies), By Therapeutic Category, By Region, And Segment Forecasts, 2024 - 2030
San
Francisco, 12 June 2024: The Report Regenerative
Medicine Market Size, Share & Trends Analysis Report By Product
(Cell-based Immunotherapies, Gene Therapies), By Therapeutic Category, By
Region, And Segment Forecasts, 2024 – 2030
The increasing awareness regarding
advanced medical therapies supports the global regenerative medicine market
demand. In addition, a strong investigational pipeline of promising candidates
and expected approvals in the coming years are projected to favor market
expansion. Furthermore, advancements in nanotechnology and the increasing
prevalence of degenerative disorders have emphasized research to introduce
novel regenerative therapies.
Recent advancements in biological therapies
have resulted in a gradual shift in preference toward personalized medicinal
strategies over the conventional treatment approach. This has created
opportunities for companies that are involved in the development of biological
therapeutics. Furthermore, the rise in the incidence of degenerative disorders
has led to an increase in focus on research to discover novel regenerative
therapies.
According to a study by Grand View
Research, in 2023, the global market size of regenerative medicine [SB1] was valued at USD 30.4 billion and is
anticipated to expand at a CAGR of 16.8% from 2024 to 2030. Regenerative
medicines have the exceptional ability to modify the elemental mechanisms of
diseases. Regenerative therapies in trials deliver favorable resolutions for
certain chronic indications. These solutions involve the use of multiple
approaches and products, such as gene therapy, tissue-engineered products,
small molecules, biologics, allogeneic & autologous stem cells, and
combinational products. Supportive initiatives from governments, biotechnology
& pharmaceutical companies, and healthcare providers are projected to boost
the industry growth.
Request sample report of Regenerative Medicine Market@
https://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market/request/rs1
The presence of a strong pipeline is
one of the major drivers in the regenerative medicine market. Companies invest
heavily in R&D to upgrade their products with the latest technology and
fulfil the unmet needs of their customers.
Furthermore, with the increasing
demand for disease treatment therapies, companies have focused their efforts to
accelerate R&D for gene therapies that target the cause of disease at a
genomic level. The cell and gene therapies in the U.S. pipeline programs (Phase
I-III trials) grew from 289 in 2018 to 362 by 2024 according to the data
published by PhRMA,. This represents an increase of 25% in a single year.
Continuous advancements in this field would further boost the demand for
regenerative medicines.
Regenerative
Medicine Market Report Scope
Report
Attribute |
Details |
Market size
value in 2024 |
USD 35.47 billion |
Revenue
forecast in 2030 |
USD 90.01 billion |
Growth rate |
CAGR of 16.79% from 2024 to 2030 |
Historical data |
2018 – 2023 |
Forecast period |
2024 – 2030 |
Where
Technology meets Medicine
Novel technologies such as tissue
engineering, gene therapy, and cell-based therapies are employed in regenerative
medicine to offer augmented patient care with regeneration or replacement of
genes, cells, organs, & tissues in patients. The increasing applications of
regenerative medicine have encouraged researchers and professionals to explore
the potential of novel technologies in regenerative medicine therapeutic
models. For instance, developments in the fabrication of tissue mimics &
advanced grafts, technologies that can integrate grafts, and the host
vasculature have been gaining traction in recent years. In addition, using
immune modulation and cell injection strategies to enhance the host’s intrinsic
regenerative capacity is also set to gain traction.
On the other hand, cell sheet
technology is a relatively newer concept dependent on retrieving confluent cell
sheets from a substrate that responds to temperature. This enables the
deposition of signaling molecules, Extracellular Matrix (ECM) molecules, and
cell adhesion molecules by the cells, further assisting them to remain intact.
The adoption of successive layers of these sheets to develop constructs of
higher thickness is presently being witnessed and is explored in corneal
reconstruction.
[SB1]https://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market
Comments
Post a Comment